NCT03832413View on ClinicalTrials.gov

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

CompletedOBSERVATIONAL
Enrollment

193

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
StrokeTBIFibromyalgiaPDDAdhdABDPtsdHealthyMCIDementiaCognitive ImpairmentCognitive Decline
Interventions
DIAGNOSTIC_TEST

DELPhI (TMS-EEG analysis)

We perform an evaluation not an intervention. the DELPhI evaluation comprises of an automated analysis to EEG data recorded during TMS (Transcranial Magnetic Stimulation) to the M1L (Primary motor cortex).

Trial Locations (1)

70300

Asaf-Harophe, Rishon LeZiyyon

All Listed Sponsors
lead

QuantalX Neuroscience

INDUSTRY

NCT03832413 - Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders | Biotech Hunter | Biotech Hunter